$124 Million is the total value of Velan Capital Investment Management LP's 30 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | $8,866,350 | +48.7% | 5,185,000 | 0.0% | 7.15% | +29.1% | |
| JASPER THERAPEUTICS INC | $7,586,797 | -48.9% | 11,219,036 | 0.0% | 6.12% | -55.6% | ||
| TELA | TELA BIO INC | $5,968,696 | -21.0% | 746,087 | 0.0% | 4.81% | -31.4% | |
| OPTN | OPTINOSE INC | $4,424,139 | 0.0% | 3,596,861 | 0.0% | 3.57% | -13.1% | |
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,152,100 | +11.8% | 55,300 | 0.0% | 2.54% | -2.9% | ||
| IMGN | IMMUNOGEN INC | $3,007,365 | -15.9% | 189,500 | 0.0% | 2.43% | -26.9% | |
| NSPR | INSPIREMD INC | $2,956,175 | +30.3% | 904,029 | 0.0% | 2.38% | +13.1% | |
| GERN | GERON CORP | $1,650,420 | -34.0% | 778,500 | 0.0% | 1.33% | -42.6% | |
| ICOSAVAX INC | $1,244,883 | -22.0% | 160,630 | 0.0% | 1.00% | -32.2% | ||
| ANNX | ANNEXON INC | $1,085,001 | -33.0% | 459,746 | 0.0% | 0.88% | -41.8% | |
| EDSA | EDESA BIOTECH INC | $809,981 | -22.1% | 1,281,615 | 0.0% | 0.65% | -32.3% | |
| IFRX | INFLARX NV | $596,000 | -33.2% | 200,000 | 0.0% | 0.48% | -41.9% | |
| RZLT | REZOLUTE INC | $528,000 | -33.3% | 400,000 | 0.0% | 0.43% | -42.0% | |
| QIPT | QUIPT HOME MEDICAL CORPcall | $509,000 | -4.7% | 100,000 | 0.0% | 0.41% | -17.1% | |
| INBX | INHIBRX INC | $458,750 | -29.3% | 25,000 | 0.0% | 0.37% | -38.6% | |
| ELEV | ELEVATION ONCOLOGY INC | $329,510 | -56.4% | 497,299 | 0.0% | 0.27% | -62.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.